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Abstract: Silver nanoparticles (AgNPs) are widely used in commercial applications as antimicrobial
agents, but there have recently been increasing concerns raised about their possible environmental
and health impacts. In this study, zebrafish embryos were exposed to two sizes of AgNP, 4 and
10 nm, through a continuous exposure from 4 to 96 h post-fertilisation (hpf), to study their uptake,
impact and molecular defense responses. Results showed that zebrafish embryos were significantly
impacted by 72 hpf when continuously exposed to 4 nm AgNPs. At concentrations above 0.963 mg/L,
significant in vivo uptake and delayed yolk sac absorption was evident; at 1.925 mg/L, significantly
reduced body length was recorded compared to control embryos. Additionally, 4 nm AgNP treatment
at the same concentration resulted in significantly upregulated hypoxia inducible factor 4 (HIF4) and
peroxisomal membrane protein 2 (Pxmp2) mRNA expression in exposed embryos 96 hpf. In contrast,
no significant differences in terms of larvae body length, yolk sac absorption or gene expression
levels were observed following exposure to 10 nm AgNPs. These results demonstrated that S4
AgNPs are available for uptake, inducing developmental (measured as body length and yolk sac area)
and transcriptional (specifically HIF4 and Pxmp2) perturbations in developing embryos. This study
suggests the importance of particle size as one possible factor in determining the developmental
toxicity of AgNPs in fish embryos.
Keywords: silver nanoparticles; molecular response; continuous exposure; uptake; developmental
toxicity; embryos (D. rerio)
1. Introduction
Nanomaterials have been defined as materials with at least one dimension smaller than 100 nm [1,2].
These materials include produced nanomaterials, such as diesel exhaust materials or airborne
combustion byproducts, as well as nanosized materials which naturally occur in the environment,
such as viruses or volcanic ash [1,2]. Silver nanoparticles (AgNPs) are widely used nanomaterials in
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commercial products, with uses ranging from disinfecting medical products to household items and
water treatment [3]. In 2015, over 410 products on the global market contained AgNPs, with an annual
global production of > 550 t [4,5]. It is projected that the nanotechnology industry will continue to
grow significantly, and the specific production of AgNPs is expected to reach approximately 800 t
by 2025 [6,7]. Each year, approximately 63 t of AgNPs enter water bodies worldwide [8], leading
to predicted environmental concentrations of ~10–1800 ng/L and 40–80,000 µg/kg in surface waters
and sediments, respectively, by 2020 [9]. The potential impacts of increased AgNP concentrations on
aquatic organisms are not fully understood yet.
Exposure to AgNPs has various negative impacts on fish. Several studies have focused on
biological uptake and whether such AgNPs can cross fish embryo chorionic membranes [10–12].
Previous studies have reported that metal nanoparticles can pass through chorionic pores but do
so randomly, resulting in unpredictable effects [12]. Gao et al. [10] also observed uptake within the
embryo cardiovascular system following exposure to 1000 µg/L AgNPs (size range 50 nm) at 24 to 96 h
post-fertilisation (hpf), as well as later development abnormalities [11]. A similar exposure regime of
3–1000 µg/mL AgNPs (size range 16–58 nm) also resulted in later development abnormalities in early
medaka embryos, including chorionic membrane disruption [13]. Oxidative stress (at 0.05–120 mg/L
AgNPs), respiratory toxicity (at > 72 mg/L AgNPs) and locomotion disorders (at > 0.47 mg/L AgNPs)
have also been reported following controlled AgNP exposure in fish [13–17].
In terms of the mechanisms of AgNPs’ toxicity, several studies have suggested that the toxicity
of AgNPs is associated with the uptake of silver in the exposed organisms [18,19], yet others have
demonstrated that particulate effects are responsible [20,21]. Regarding uptake, Xin et al. [22] reported
an accumulation of AgNPs in the head and trunk region of exposed zebrafish embryos under a
static exposure with the AgNP exposure media replaced every 24 h. Similarly, Osborne et al. [23]
reported silver content in the gills and intestine of exposed adult zebrafish following an exposure
to 20–110 nm size range AgNPs for 4 days, wherein the exposure media was refreshed every third
day. Additionally, Griffitt et al. [21] detected silver in the gills and carcasses of adult female zebrafish
exposed to 26.6 ± 8.8 nm size range AgNPs for 48 h. However, major factors contributing to the uptake
and toxicity of AgNPs in fish embryos remain unclear.
Furthermore, studies using fish have shown that silver ions alone, resulting from silver
nanomaterial destabilisation, can cause oxidative stress in embryos [24] and adults [14], interfere with
gill ion pumps in adults [25], increase mortality and morphological malformations in embryos (120 hpf
at a dose of 3–100 nM) [26] and impair swimming behaviour and locomotion [15,17].
In the present study, the uptake, developmental impacts and associated molecular-level responses
of early zebrafish embryos to continuous exposure to two sizes of AgNPs (4 and 10 nm) for 4 days
without media replacement were investigated. A specific molecular-level approach was used, involving
targeted gene transcripts superoxide dismutase 2 (SOD2), catalase (CAT), hypoxia inducible factor 4 (HIF4),
peroxisomal membrane protein 2 (Pxmp2) and mucosal secretion protein (Muc), which are representative of
oxidative stress and membrane functions.
2. Results
2.1. Characterisation of AgNPs
The S4 AgNPs used in the study consisted of spherical shapes under TEM observation, with an
average diameter of 5.14 ± 2.17 nm (Figure 1A). The size distribution histograms (Figure 1C) reveal
that the size of S4 AgNPs ranged mainly from 3.7 to 5.7 nm. The S10 AgNPs used also consisted of
spherical shapes under TEM observation, with an average diameter of 9.89 ± 2.03 nm (Figure 1B). The
size distribution histograms (Figure 1D) reveal that the size of S10 AgNPs mainly ranged from 7.9 to
14.5 nm. TEM images also indicate that the AgNPs had a homogeneous dispersion in the aqueous
solution (Figure 1A,B).
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Figure 1. Transmission electron microscopy images of S4 (A) and S10 (B) silver nanoparticles (AgNPs). 
Histograms of the size distribution for S4 (C) and S10 (D). 
2.2. Embryo Body Length and Yolk Sac Area Impacts 
Exposure to S4 AgNPs disturbed the development of zebrafish larvae, including decreased body 
length (Figure 2A) and delayed yolk sac absorption (Figure 2B). Mean body length of zebrafish 
embryos at 72 hpf was significantly decreased when exposed to the highest dose (1.925 mg/L) of S4 
AgNPs treatment compared to control embryos (Figure 3A). No significant differences in body length 
at the lower dose levels of S4 AgNPs were observed (Figure 3A). Similarly, yolk sac area (mm2) was 
significantly increased when exposed to the two highest doses (0.963 and 1.925 mg/L) of S4 AgNPs 
treatment compared to control embryos (Figure 3B). No significant differences in yolk sac area at the 
lower S4 AgNP dose levels were observed (Figure 3B). There was a trend of the yolk sac area of 
zebrafish larvae in the S4 AgNPs treatment groups to increase with increasing concentrations of 
AgNPs. Exposure to S10 AgNPs had no significant observable effects on body length or yolk sac area 
at all studied concentrations. 
  
Figure 1. Transmission electron microscopy i ages of S4 (A) and S10 (B) silver nanoparticles (AgNPs).
Histograms of the size distribution for S4 ( ) 10 (D).
2.2. Embryo Body Length and Yolk Sac Area Impacts
Exposure to S4 AgNPs disturbed the l ent of zebrafish larvae, including decreased body
length (Figure 2A) and delayed olk sac absorption (Figure 2B). Mean body length of zebrafish embryos
at 72 hpf was significantly decreased when exposed to the hig est dose (1.925 mg/L) of S4 AgNPs
treatment compared to control embryos (Figure 3A). No significant differences in body length at
the lower dose levels of S4 AgNPs were observed (Figure 3A). Similarly, yolk sac area (mm2) was
significantly increased when exposed to the two highest doses (0.963 and 1.925 mg/L) of S4 AgNPs
treatment compared to control embryos (Figure 3B). No significant differences in yolk sac area at
the lower S4 AgNP dose levels were observed (Figure 3B). There was a trend of the yolk sac area
of zebrafish larvae in the S4 AgNPs treatment groups to increase with increasing concentrations of
AgNPs. Exposure to S10 AgNPs had no significant observable effects on body length or yolk sac area
at all studied concentrations.In . J. Mol. S i. 2020, 21, x FOR PEER REVIEW 4 of 15 
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Figure 2. Representative phenotypes of zebrafish embryos upon exposure to AgNP concentration of 
(B) 1.925 mg/L, compared with the control (A) at 72 hpf. Scale bar = 500 μm. 
 
Figure 3. Percentage change of (A) body length and (B) yolk sac area of zebrafish embryos following 
exposure to AgNPs (at 0.481, 0.963, 1.925 mg/L) compared with the control (without AgNPs) at 72 hpf. 
Values represent mean ± standard error. Results have been normalised on control (0 µg/L). The body 
length of control embryos was (3.618 ± 0.047) mm (S4) and (3.603± 0.009) mm (S10), and the yolk sac 
area of control embryos was (0.328 ± 0.014) mm2 (S4) and (0.333 ± 0.011) mm2 (S10). * significant 
difference between samples and the control groups using one-way ANOVA. * p < 0.05. n = 4. 
2.3. AgNP Uptake 
Figure 2. Repr sentative phenotypes of zeb fi bryos upon exposure to AgNP concentration of
(B) 1.925 mg/L, compared with the control (A) at 72 hpf. Scale bar = 500 µm.
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Figure 3. Percentage change of (A) body length and (B) yolk sac area of zebrafish embryos following
exposure to AgNPs (at 0.481, 0.963, 1.925 mg/L) compared with the control (without AgNPs) at 72 hpf.
Values represent mean ± standard error. Results have been normalised on control (0 µg/L). The body
length of contr l embryos was (3.618 ± 0.047) m ( (3.603± .009) m (S10), and the yolk sac
area of control embryos was (0.328 ± 0. 14) mm2 (S .333 ± .011) m2 (S10). * significant
difference between samples and the control groups usi e- ay ANOVA. * p < 0.05. n = 4.
2.3. AgNP Uptake
ICP-MS analysis revealed that zebrafish embryos took up AgNPs (Figure 4), with significant
uptake at higher concentrations of S4 AgNPs over 0.963 mg/L. Even at a low concentration of 0.481 mg/L,
there was an increased uptake of silver content in the exposed fish embryos, although the amount was
not significant. Silver content did not significantly increase following exposure to any concentration of
the S10 size range AgNPs (Figure 4). Similarly, however, an increased silver content level was observed
in the S10 AgNP treatment groups (Figure 4) as compared to the blank control. The silver content in
fish embryos reached around 20 ng/g wet weight at higher dose treatments.
2.4. qPCR Analysis of Candidate Gene Expression in Fish Embryos
The expression level of each target mRNA was analysed in controls, silver-ion-treated and S4-
and S10-AgNP-treated (1.925 mg/L) D. rerio embryos using qPCR (Figure 5). HIF4 and Pxmp2 mRNA
expression was significantly upregulated (p < 0.05) following treatment with 1.925 mg/L of S4 AgNPs
relative to control embryos (Figure 5C,D). SOD2, CAT and Muc mRNA expression levels showed no
significant changes in AgNP-treated embryos compared with corresponding control embryo samples
(Figure 5A,B,E). No significant differences in any of the gene expression levels were observed following
exposure to S10 size range AgNPs or silver ions alone (Figure 5A–E).
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genes in zebrafish embryos at 96 hpf following exposure to AgNO3 (18 µg/L Ag+), S4 AgNPs (1.925 
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0.05. n = 4. 
Figure 5. qPCR mRNA transcript levels for (A) SOD2, (B) , (C) HIF4, (D) Pxmp2 and (E) Muc genes
in zebrafish embryos at 96 hpf following exposure to AgNO3 (18 µg/L Ag+), S4 AgNPs (1.925 mg/L),
and S10 AgNPs (1.925 g/L). Values ep esent m an ± standard error. * significan difference between
samples and the control groups using either two-sample t-test or Mann–Whitney test. * p < 0.05. n = 4.
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3. Discussion
For the first time, this study provided a link between AgNP exposure and uptake and perturbation
of membrane protein mRNA expression, as well as previously reported hypoxia inducible factor gene
expression, in fish. Specifically, we were the first to observe significantly increased expression of
a membrane transporter protein, Pxmp2, and hypoxia inducible factor HIF4 mRNA expression in
zebrafish embryos exposed to small size range (4 nm) AgNPs.
The size of the AgNPs may be one important factor, among many, in determining their availability
in fish embryos. This study provided evidence for significantly enhanced uptake and developmental
toxicity of smaller sized AgNPs with a diameter of 4 nm, as compared to that of 10 nm AgNPs in
zebrafish embryos. The ICP-MS data showed that exposure to S4 AgNPs from 4 to 96 hpf resulted in
significantly enhanced silver uptake in zebrafish larvae, while no significant differences were observed
in the silver uptake levels upon exposure to S10 AgNPs. Previous studies have shown that the size
(and coating/suspension media) of AgNPs can determine the level of uptake [11,26,27], suggesting
that the smaller size ranges up to 20 nm are more likely to be taken up than larger sized AgNPs.
Bar-Ilan et al. [26] also reported that the biological impacts observed, including various morphological
malformations and yolk sac oedema, significantly increased following exposure to 3 nm range AgNPs
from 4–120 hpf. Correspondingly, our observations were that the body length was significantly reduced
while yolk sac diameter was increased at the highest concentration of 1.925 mg/L for S4 AgNP exposure.
In contrast, Muth-Kohne et al. [28] reported a decrease in egg yolk sac size following exposure to
AgNPs (< 20 nm size) at 48 hpf, using a significantly higher dose of 73 mg/L. It is known that silver can
accumulate in tissues both in the form of ions and in the form of nanoparticles [29]. The silver content
measurement result in the present study could not ascertain the form of metal inside the tissue, which
is one of the drawbacks of using ICP-MS to examine the uptake of nanometals. The overall uptake of
silver content in zebrafish larvae in the present study was relatively low, which might have been due
to the surface coating used in the studied AgNPs. Particle size and surface charge of nanoparticles
were shown to have significant impacts on nanoparticles’ toxicity and interactions with biological
membranes [30]. In the present study, both S4 and S10 AgNP exposure generated a low toxicity effect
in the treated fish embryos, with a slightly enhanced toxic effect with S4 AgNPs.
During the development of zebrafish (Danio rerio), baby fish hatch from around 48 hpf. Before
hatching, the uptake of AgNPs in zebrafish embryos is affected by the chorion. The zebrafish embryo
is enclosed by the chorion, which acts as a protective barrier against external toxic substances. The
zebrafish chorion has pores of 0.5–0.7 µm diameter [11,31], which are necessary for oxygen and nutrient
transportation for the embryos [32]. Arguably, the AgNPs entering the chorion represent an opportunity
for uptake of AgNPs in the embryo tissues [12,18,33] or for later development abnormalities [11,13].
Compared to S10 AgNPs, S4 AgNPs with a smaller size have a larger surface area that can enhance
their adherence to the embryo chorion, which may contribute to the developmental toxicity of AgNPs
by blocking the chorion pores and thus obstruct the oxygen exchange.
After hatching, it is possible that both S4 and S10 AgNPs were taken up as food items and entered
the body in that way, which might have contributed to the majority of uptake and toxicity of AgNPs. It
has been reported that smaller particles have higher dissolution rates than larger particles due to their
increased surface area [23]. As a result, the smaller sized AgNPs are more efficient carriers for local
release and deposition of Ag ions in the fish body [11], which could result in site-specific disruption
of Naþ/Kþ ATPase activity in the basolateral membranes [23]. As Naþ/Kþ ATPase activity has been
reported to also be involved in the formation of tight junctions [34], disintegration of these adhesion
sites could allow even more particle entry [35]. Osborne et al. [23] previously showed that silver
content in the gills of adult zebrafish had significantly higher proportions of 20 nm silver particles than
110 nm particles after exposure for both 4 h and 4 days.
In terms of molecular response, several studies have previously analysed various gene expressions
in fish species in response to AgNP exposure, reporting significant changes in oxidative or
general stress [13,14,16,27], toxicological [36,37] and morphological/neural development end-point
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markers [16,22]. HIF4 mRNA expression was significantly elevated in S4-AgNP-treated embryos,
which was indicative of a hypoxic cellular environment. Increased HIF4 mRNA expression was
consistent with another study that investigated medaka fish embryo lactate dehydrogenase (LDH)
activity, which is regarded as a biomarker of hypoxic regulation in organisms/cells [13]. Wu and
Zhou [13] also reported that medaka fish embryos exposed to AgNPs of size range 15–50 nm showed a
dose-dependent (63–1000µg/L) increase in LDH activity after three days of exposure. HIF-1α expression
was also reported to be upregulated in adult fish (P. promelas) following exposure to 61.4 µg/L of poly
(N-vinylpyrrolidone) AgNPs for 96 h [38]. It is thus evident, and consistent with the wider literature,
that exposure to AgNPs at 1.925 mg/L resulted in a hypoxic and stressful environment within the
embryos as measured at 96 hpf.
The increased expression of Pxmp2 mRNA in embryos exposed to AgNPs was an important novel
finding. This gene encodes a channel-forming protein that has so far only been characterised in the
mammalian peroxisomal membrane, and is considered important in facilitating the continual flow of
small solutes [39]. The Pxmp2 channel is estimated to have a diameter of 1.4 nm, with weak cation
selectivity, and operates as a general diffusion pore in the membrane [39]. Both SOD and CAT enzymes
are located within the peroxisome organelle, which scavenge for reactive oxygen species, specifically
the oxygen (O2.-) free radical and hydrogen peroxide (H2O2), respectively, leading to the hydroxyl OH
radical in the cell [40]. The increased Pxmp2 and SOD mRNA expressions may thus have been related
to an increase in O2.- levels within the AgNP-treated embryos at the early 96 hpf time point. Increased
SOD activity following > 250 µg/L AgNP exposure has also been reported in medaka embryos up to
72 hpf, but was then reportedly followed by a decrease back to control values by the end of embryonic
development [13]. In contrast, expression of SOD1 mRNA in liver tissues of adult zebrafish and carp
has been reported to be unaffected by treatment with significantly higher dose levels of 30, 60 and
120 mg/L [14] or lower dose levels of 25–200 µg/L of AgNPs after 48–96 h [41].
Muc mRNA expression levels in embryos were not altered as a result of either AgNP or silver ion
exposure at the dose levels investigated. Muc is one of five mucin genes characterised in zebrafish,
encoding a protein that forms a gel-based protective barrier in several tissues of adult fish, as well as in
the head and tail region of a developing embryo, detectable from 48 hpf [42]. Studies using adult fish
have previously investigated alterations in mucus secretion upon AgNP exposure [19], although no
previous studies have focused on the mucus’ protective role in early-development embryos.
Any observed bioaccumulation of silver in embryos may have been due to both AgNPs and free
silver ions. This could be part of the reason why previous studies have chosen to compare the toxicity
effects of AgNPs and silver ions. The toxicity of AgNPs has been extensively compared with silver
ion exposure alone. A summary of the current knowledge on toxicity impacts of AgNPs and silver
ion is shown in Table 1. The literature reports (Table 1) that exposure to either AgNPs or silver ions
alone may induce similar phenotypic abnormalities, such as formation of oedema [43], slower swim
bladder inflation [20], decreased ATPase enzyme activity [23] and altered expression of similar genes
associated with oxidative phosphorylation, detoxifying processes and protein synthesis [18,22,44]. In
terms of contrasting impacts between AgNPs and silver ions alone, exposure to AgNPs alters the gene
expression of metal-sensitive metallothioneins [22], while no such silver ion induction has been reported
to date. AgNP exposure also induces delayed hatching [43], yet silver ions accelerate hatching [45].
It is evident that there may be some shared toxicity mechanisms between AgNPs and silver ions,
while other mechanisms may be unique. In this study, silver ion exposure alone did not induce the
same oxidative stress or Pxmp2 response at the concentrations studied, suggesting that the molecular
responses were specific to the nanoparticles rather than to any disassociated metal ion elements. The
nanomaterial coating may also be a confounding factor in toxicity assessments [20,24,30,46], though
oleic acid was used in the present study and is regarded as non-toxic [47]. AgNPs coated with fatty
acid (oleic acid), used in the present study, are quite stable and do not dissolute as much silver ion as
previously reported [22,48]. The limited release of silver ion from the AgNPs used might explain the
observed limited toxicity in fish embryos.
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Table 1. A summary of the observed toxicity impacts of AgNPs and silver ions reported in the literature.
Organism Source Exposure Period NP Sizes Exposure Concentration Ag Uptake ofNegative Control Ag Uptake Biological Effects References
Zebrafish
Embryos
AgNPs
0–4 days
3–8 nm 0.1 and 0.125 mg/L
— —
Induced delayed hatching and
formation of oedema.
[43]
AgNO3 — 0.04 and 0.08 mg/L
Ag+ decreased absorption of yolk sac
and resulted in pericardial oedema.
Zebrafish
Embryos
AgNPs
6–120 hpf
10 nm 1.7 and 5.1 mg/L
— —
AgNPs induced slowed swim bladder
inflation. [20]
AgNO3 — 0.51, 1.7 and 5.1 mg/L Ag+ slowed swim bladder inflation.
Zebrafish
Embryos
AgNPs 4–24 and4–48 hpf 10 nm 0.005 mg/L
— —
AgNPs altered gene expression
associated with oxidative
phosphorylation and protein
synthesis. [44]
AgNO3 4–24 hpf — 0.00025 mg/L
Ag+ altered oxidative phosphorylation
and protein synthesis gene expression.
Adult
Zebrafish
AgNPs
0–4 days
20 nm
1 mg/L
Gill and intestine:
No uptake
detected
Gill: 5.11 µg/adult
Intestine: 0.68 µg/adult
AgNPs decreased ATPase enzyme
activity. [23]
AgNO3 —
Gill: 1.66 µg/adult
Intestine: 2.29 µg/adult
Ag+ decreased ATPase enzyme
activity.
Zebrafish
Embryos AgNPs 4–96 hpf 10 nm 1.925 mg/L
Head and trunk:
No uptake
detected
Head: 0.03 ng/embryo
Trunk: 0.05 ng/embryo
AgNPs induced small head, small eye
and cardiac defects, and altered the
gene expression of neural
development-related, metal-sensitive
metallothioneins, and detoxification.
[22]
Zebrafish
Embryos AgNPs 4–96 hpf 4 nm 1.925 mg/L
Whole body
tissue:
no uptake
detected
Whole body tissue: 21.47
ng/g
AgNPs decreased body length,
delayed yolk sac absorption, and
altered oxidative stress and
channel-forming protein gene
expression.
This study
Adult
Zebrafish AgNPs 0–48 h 26.6 ± 8.8 nm 1 mg/L Carcass: 0.02 ng/g Carcass: 0.47 ng/g
AgNPs altered signal transducer
activity, enzyme activity and
membrane function gene expression.
[21]
Zebrafis
Embryos AgNO3
1–24, 1–48
or 1–96 hpf — 0.02 mg/L — —
Ag+ altered detoxifying processes and
oxidative stress gene expression. [44]
Whitefis
Embryos AgNO3 hatch — 0.1 mg/L — —
Ag+ accelerated hatching and
decreased absorption of yolk sac. [46]
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4. Materials and Methods
4.1. Materials and Characterisation of AgNPs
AgNPs were purchased in powder form from Suzhou Cold Stones Technology Co., Ltd. (Suzhou
Cold Stones Technology Co. Ltd., Suzhou, China). AgNPs had an approximate diameter of 4 or 10 nm,
designated as S4 and S10 AgNPs, and were coated with 10%–13% fatty acid (oleic acid). AgNO3 (CAS
7761–88-8, 99% purity) used for the gene expression control group was supplied by Sigma-Aldrich (St.
Louis, MO, USA).
The properties of AgNPs were characterised by transmission electron microscopy (TEM), and
TEM images were taken using a JEOL JEM-2100 TEM microscope (Jeol Ltd., Tokyo, Japan). AgNPs
were dispersed in deionised water and sonicated at 40 kHz for 20 min. A small drop of the suspension
was placed on a copper grid and air-dried at room temperature. The TEM images were used to provide
information on the structure, size, size distribution and morphology of the S4 and S10 range AgNPs.
4.2. Zebrafish Maintenance and Embryo Collection
Wild-type adult zebrafish were kept in a laboratory fish tank at 28 ◦C with a cycle of 14:10 h of
light:dark, in a closed flow-through system with charcoal-filtered tap water [49]. The fish were fed
twice a day with dry flake feed and brine shrimp. Before egg collection, female and male fish were
placed in a clean breeding tank at a sex ratio of 1:2. Spawning was induced in the morning when the
lights came on after the 10 h dark period. Embryos were then collected 0.5 h later and rinsed with
system water. Collected eggs were washed with clean water and then screened under a dissection
microscope (SMZ168, Motic, Xiamen, China). The developmental stage of embryos was identified
according to Kimmel et al. [50].
4.3. Exposure Design
Healthy fish embryos were selected and transferred at 4 hpf into 12 well cell culture plates
containing 3 mL of fish culture solution in each well. Experiments were conducted, and ethical
approval sought, in accordance with the rules and guidelines of the institution and country. The
dispersed S4 AgNPs were prepared at concentrations of 0.481, 0.963 and 1.925 mg/L. The dispersed
S10 AgNPs were also prepared at concentrations of 0.481, 0.963 and 1.925 mg/L. All treatments were
performed in quadruplicate with 40 embryos in each replicate, and 160 embryos exposed in total for
each dose. Treatment lasted from 4 hpf to 96 hpf in a dark environment without media replacement.
Two independent exposure experiments were prepared: one for the morphological observation and
ICP-MS analysis, and the other for the mRNA expression analysis. For the control treatment groups,
one control comprised medium only (‘control’); for the gene expression analysis only, there was a
second control treatment group containing silver ions as AgNO3 (0.018 mg/L of Ag+) (‘AgNO3 control’).
Similarly, the control treatment groups comprised four wells, each containing 40 individual embryos.
In the morphological observation and ICP-MS analysis, 40 embryos from each concentration (10
embryos per replicate and four replicates per treatment) were randomly selected for photography. The
embryos were anaesthetised with 0.024% tricaine (Sigma-Aldrich) at 72 hpf. The body length and yolk
sac area of the embryos were examined under a Zeiss stereomicroscope (V8, Göttingen, Germany),
equipped with an AxiocamICc3 photomicrography system. After the measurement, the larvae were
returned to the well for the 96 hpf exposure period ICP-MS analysis. In the mRNA expression analysis,
embryos were stored at 96 hpf in RNAlater® solution at −80 ◦C until quantitative (Q) PCR analysis.
4.4. Uptake of AgNPs in Fish Embryos
The uptake of AgNPs was studied by measuring the silver content in the exposed zebrafish
embryos at 96 hpf. As a pre-treatment, to remove surface AgNPs on the embryos, 40 embryos in each
replicate were washed three times with 1× phosphate-buffered saline. For digestion, embryos were
dissolved with 2 mL of concentrated HNO3 for 2 h at 180 ◦C; 1 mL of 30% H2O2 was added for the
Int. J. Mol. Sci. 2020, 21, 1876 10 of 14
following 1 h at 120 ◦C. The samples were then diluted to a final concentration of 2% HNO3 with
deionised water. The pre-treatment of the samples was carried out according to previous reports [22,51]
to determine the silver content using inductively coupled plasma-mass spectrometry (ICP-MS; Neptune;
Thermo Fisher Scientific, MA, USA). The wet weight of each replicate was measured, and silver content
was calculated via (total silver/wet weight) for each replicate. The background silver content in the
tissues of control fish was subtracted from that of the treated samples. The charcoal-filtered tap water
used to breed the parental adult zebrafish contained a small amount of silver [52,53]. A total of 160
embryos for each concentration (40 embryos per replicate and four replicates per treatment) were used
for ICP-MS measurement.
4.5. Target Gene Isolation and Characterisation
Total RNA was extracted from embryos exposed to the S4 and S10 AgNPs and treatment
control AgNO3 collected at 96 hpf, as well as the corresponding control treatment group, using the
manufacturers protocol (Roche Diagnostics GmbH, Mannheim, Germany). To assess the integrity
of total RNA, samples were analysed on a denaturing agarose gel stained with ethidium bromide
(Invitrogen™, Waltham, MA, USA). cDNA was prepared using SuperScript VILO cDNA synthesis
reagents and its protocol (Life Technologies, Paisley, U.K.), with 14 µL (100 ng) of total RNA. In a
0.2 mL tube, the following reagents were added: 4 µL of 5× VILOTM Reaction Mix (includes random
primers, MgCl2, and dNTPs in a buffer formulation) and 2 µL of 10X Superscript enzyme mix. Each
reaction was incubated at 25 ◦C for 10 min, and then 60 min at 42 ◦C, followed by 5 min at 85 ◦C and
a holding step at 4 ◦C. To degrade any remaining RNA, the following reagents were added: 0.5 µL
(5 units) of RNase H (supplied in 100 mM KCl, 20 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 0.1 mM
EDTA, 0.1 mM dithiothreitol and 50% glycerol) and 2 µL of 10X RNase H Reaction Buffer (includes
75 mM KCl, 50 mM Tris-HCl, 3 mM MgCl2, 10 mM MgCl2 in pH 8.3 at 25 ◦C). All reagents were mixed,
incubated at 37 ◦C for 45 min and then stored at −20 ◦C.
For the generation of SOD2, CAT, HIF, Pxmp2 and Muc PCR products, 1 µL of cDNA was combined
with 0.5 µL of 10 mM dNTPs, 5 µL of amplification buffer, 0.5 µL of 0.5–4.5 mM MgCl2, 0.5 µL of
1.5 µM of each sense and antisense primers (Table 2) and 0.25 µL (1.25 units) of Herculase II fusion
DNA polymerase (Agilent Technologies, Santa Clara, CA, U.S.A.) for a total reaction volume of
25 µL. Elongation factor 1 (EF1), 18S rRNA (18S) and β tubulin were evaluated as potential reference
genes. Amplifications were carried out using the TC-4000 Thermal Cycler (Techne, Staffordshire, U.K.)
equipped with a heated lid. All reactions were initially denatured at 94 ◦C for 30 s, then cycled 35 times
with 30 s denaturation at 94 ◦C, 30 s annealing at 50/55/60 ◦C and 30 s elongation at 72 ◦C. Finally, a
2 min extension step was conducted at 72 ◦C. The PCR fragments were sequenced commercially by
Macrogen (Amsterdam, Netherlands). Identities of PCR fragments were verified using a blast search
on the NCBI database (http://blast.ncbi.nlm.nih.gov/Blast.cgi), and aligned using a multiple sequence
alignment program, Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/).
Table 2. Primer pairs used for the isolation of candidate and reference genes from zebrafish embryos.
Targeted
Transcript Forward Primer (5
′-3′) Reverse Primer (5′-3′) Amplicon Size(bp)
18S TAGAGGGACAAGTGGCGTTC CCTCGTTGATGGGAAACAGT 195
EF1 GATGCACCACGAGTCTCTGA TGATGACCTGAGCGTTGAAG 158
MUC TGGGATCGCAAAACCACTGT GTTGTGCATCAGGGCAAGTG 187
PXMP2 AGTTACTGGCCTGCGATGAA CACTGCAGTAAGGCACAACC 157
HIF AGACTGCCACGGAAAAGCTA CCAGAGGCAGAAGAGCAGTT 161
CAT GCGGATACCAGAGAGAGTCG ATCTGATGACCCAGCCTCAC 172
SOD2 AGCGTGACTTTGGCTCATTT ATGAGACCTGTGGTCCCTTG 166
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4.6. Quantitative (Q) PCR Analysis of mRNA Expression
qPCR was carried out using 20 µL reaction volumes consisting of 10 µL of SYBR® Green Master
Mix (Roche, U.K.), 7 µL of sterilised water, 1 µL of the cDNA template and 2 µL of optimised primer
concentration (EF1, CAT, HIF: 200 nM; 18S, Pxmp2, Muc: 300 nM, SOD2: 400 nM). Two reference genes
(EF1 and 18S) were determined to be the most stable across treatment groups using geNorm software.
Amplifications were carried out using the CFX96™ Real-Time PCR system, C1000™ Thermal
Cycler (Bio Rad, Watford U.K.), in duplicate and with negative controls. Reactions started with
denaturation at 50 ◦C for 2 min, 95 ◦C for 10 min, followed by 40 cycles of a three-step protocol starting
with denaturation at 95 ◦C for 10 s, followed by annealing at 60 ◦C for 1 min, then 72 ◦C for 1 min. At
the end, a melting/dissociation curve was established. A relative quantification method was used to
determine changes in target gene expression in the treatment group compared to untreated control
samples, using the geomean of the reference genes for normalisation and the ∆Ct method [54].
4.7. Statistical Analyses
The particle size of the AgNPs, the zebrafish larvae body length and yolk sac area were all
measured and calculated using ImageJ2x (National Institutes of Health, Bethesda, MD, USA) and
GraphPad Prism 5 (GraphPad Software, La Jolla, CA, USA). Significant difference in body length/yolk
sac area was determined using single-way analysis of variance and Dunnett’s post hoc test. The
analysis of variance was performed with GraphPad Prism 5 (p < 0.05). Significant difference in relative
gene expression was tested using either a two-sample t-test or Mann–Whitney U test (SPSS, Version 22,
IBM Corp. New York, NY, USA).
5. Conclusions
In summary, we studied the comparative uptake and developmental toxicity of 4 and 10 nm size
range AgNPs in zebrafish embryos. Under the exposure conditions used in this study, S4 AgNPs at the
higher dose level (of 1.925 mg/L) were taken up by zebrafish embryos. The uptake was correspondingly
associated with significant developmental toxicity (delayed development). Transcription of two genes
related to hypoxia and membrane transport was impacted by S4 AgNPs but not S10 AgNPs. A stable
surface coating may help to limit the release of silver ion and associated toxicity of studied AgNPs in
fish embryos, and particle size may also act as another possible factor in determining the uptake and
developmental toxicity of AgNPs in fish embryos.
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